Among the 69 tumor specimens tested, the relative SATB1 mRNA level (tumor tissue vs. matching unchanged mucosa of CRC patients) was decreased in 51 (73.9 %) tumors while it was increased in 18 (26.1 %) cases (Table 2). This evidence concerns the gene SATB1 and colorectal carcinoma.